RLI.NYSERli CORP

Form 4: RLI CFO Bryant Granted Stock Options Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


RLI Corp.'s Chief Financial Officer, Todd Wayne Bryant, was granted 6,250 stock options at an exercise price of $58.66, effective November 3, 2025, under a Rule 10b5-1 plan.

Summary

  • Todd Wayne Bryant, Chief Financial Officer of RLI Corp. (RLI), was granted 6,250 stock options.
  • The transaction date for the grant was November 3, 2025.
  • The exercise price for these stock options is $58.66 per share.
  • The options will become exercisable in 20% increments annually, commencing one year from the grant date (November 3, 2026).
  • The options have an expiration date of November 3, 2033.
  • The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The grant of stock options to a key executive is generally a positive event, as it aligns management's interests with shareholders and serves as an incentive for long-term performance. The use of a 10b5-1 plan also indicates good governance.

Positives

  • The grant of stock options aligns the Chief Financial Officer's long-term interests with those of RLI Corp.'s shareholders.
  • The use of a Rule 10b5-1 plan demonstrates a proactive approach to compliance and transparency regarding insider transactions.

Future Outlook

The stock option grant provides a long-term incentive for the Chief Financial Officer, aligning future performance with shareholder value creation over the vesting and exercise period.

Industry Context

Executive stock option grants are a common component of compensation packages in the financial services and insurance industries, designed to incentivize long-term performance and align management interests with shareholders. The use of a Rule 10b5-1 plan is standard practice for managing insider trading compliance.

Comparison to Industry Standards

  • The grant of stock options to a Chief Financial Officer is a standard practice for executive compensation across various industries, including insurance, to foster long-term commitment and performance.
  • The vesting schedule of 20% annually over five years is a common structure for equity awards, comparable to practices at companies like Chubb Limited or The Travelers Companies, Inc., which also utilize multi-year vesting to retain talent and incentivize sustained performance.
  • The establishment of a Rule 10b5-1 plan for such transactions is a widely adopted corporate governance best practice, similar to those implemented by most publicly traded companies to ensure compliance with insider trading regulations.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Insider Trading Policy ComplianceThe transaction was made pursuant to a Rule 10b5-1(c) plan, which allows insiders to set up pre-planned trades to avoid accusations of insider trading.11/03/2025Enhances transparency and compliance regarding executive equity transactions, mitigating potential insider trading concerns.

Stakeholder Impact

  • Shareholders: The grant of stock options to the CFO is intended to align management's financial interests with shareholder value creation, potentially leading to improved long-term performance.
  • Employees: This transaction is specific to a key executive and does not directly impact the broader employee base, though it reflects the company's executive compensation strategy.

Next Steps

  • The stock options will begin to vest on November 3, 2026, with 20% becoming exercisable annually thereafter.
  • The Chief Financial Officer may choose to exercise vested options at any point before the expiration date of November 3, 2033.

Key Dates

DateDescription
11/03/2025Date of earliest transaction (stock option grant date)
11/03/2026Date when the first 20% of stock options become exercisable
11/03/2033Expiration date of the stock options
11/04/2025Signature date of the reporting person on the Form 4

Keywords

RLI Corp, RLI, Todd Wayne Bryant, CFO, Stock Options, Executive Compensation, Insider Transaction, Form 4, Rule 10b5-1, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.